Phosphine‐Catalyzed Synthesis and Cytotoxic Evaluation of Michael Adducts of the Sesquiterpene Lactone Arglabin
ChemMedChem · 2024
DOI: 10.1002/cmdc.202400045 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Alexey V Salin und 6 weiteren Autor:innen. Beteiligte Einrichtung: A.M. Butlerov Institute of Chemistry, Kazan Federal University, Kremlevskaya Street, 18, Kazan, 420008, Russian Federation. Hauptthemen laut MEDLINE: Antineoplastic Agents, Phosphines, Drug Screening Assays, Antitumor, Lactones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
A general method for chemo‐ and diastereoselective modification of anticancer natural product arglabin with nitrogen‐ and carbon‐centered pronucleophiles under the influence of nucleophilic phosphine catalysts was developed. The locked s‐ cis ‐geometry of α‐methylene‐γ‐butyrolactone moiety of arglabin favors for the additional stabilization of the zwitterionic intermediate by electrostatic interaction between phosphonium and enolate oxygen centers, leading to the unprecedentedly high efficiency of the phosphine‐catalyzed Michael additions to this sesquiterpene lactone. Using n ‐Bu 3 P as the catalyst, pyrazole, phthalimide, 2‐oxazolidinone, 4‐quinazolinone, uracil, thymine, cytosine, and adenine adducts of arglabin were obtained. The n ‐Bu 3 P‐catalyzed reaction of arglabin with active methylene compounds resulted in the predominant formation of bisadducts bearing a new quaternary carbon center. All synthesized Michael adducts and previously obtained phosphorylated arglabin derivatives were evaluated in vitro against eleven cancer and two normal cell lines, and the results were compared to those of natural arglabin and its dimethylamino hydrochloride salt currently used as anticancer drugs. 2‐Oxazolidinone, uracil, diethyl malonate, dibenzyl phosphonate, and diethyl cyanomethylphosphonate derivatives of arglabin exhibited more potent antiproliferative activity towards several cancer cell lines and lower cytotoxicity towards normal cell lines in comparison to the reference compounds, indicating the feasibility of the developed methodology for the design of novel anticancer drugs with better therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- A.M. Butlerov Institute of Chemistry, Kazan Federal University, Kremlevskaya Street, 18, Kazan, 420008, Russian Federation.
- Laboratory for structural analysis of biomacromolecules, Kazan Scientific Center of Russian Academy of Science, Kremlevskaya Street, 31, Kazan, 420008, Russian Federation.
- Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center of Russian Academy of Sciences, Arbuzov Street, 8, Kazan, 420088, Russian Federation.
ORCID-Profile: Alexey V Salin
Förderung
- Russian Science Foundation
Zitieren
APA
Salin, A. V., Shabanov, A. A., Khayarov, K. R., Islamov, D. R., Voloshina, A. D., Amerhanova, S. K., & Lyubina, A. P. (2024). Phosphine‐Catalyzed Synthesis and Cytotoxic Evaluation of Michael Adducts of the Sesquiterpene Lactone Arglabin. ChemMedChem. https://doi.org/10.1002/cmdc.202400045
Vancouver
Salin AV, Shabanov AA, Khayarov KR, Islamov DR, Voloshina AD, Amerhanova SK, et al. Phosphine‐Catalyzed Synthesis and Cytotoxic Evaluation of Michael Adducts of the Sesquiterpene Lactone Arglabin. ChemMedChem. 2024. doi:10.1002/cmdc.202400045
BibTeX
@article{Salin2024,
author = {Salin, Alexey V and Shabanov, Andrey A and Khayarov, Khasan R and Islamov, Daut R and Voloshina, Alexandra D and Amerhanova, Syumbelya K and Lyubina, Anna P},
title = {Phosphine‐Catalyzed Synthesis and Cytotoxic Evaluation of Michael Adducts of the Sesquiterpene Lactone Arglabin},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202400045}
}
EUVIMED